Low Helicobacter pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil

BMC Gastroenterology

Volumn 13, Issue 1, 2013, Pages

  Suzuki, Rodrigo Buzinaro ^a,b   Lopes, Rodrigo Augusto Basso ^a   da Câmara Lopes, George Arouche ^a   Hung Ho, Tin ^a   Sperança, Márcia Aparecida ^a,b  

^a Marilia Medical School   (Brazil)

^b UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

Clarithromycin resistance; Gastric diseases; Helicobacter pylori; Helicobacter pylori 23S rDNA; Nucleic acid based diagnostic

Indexed keywords

ADENINE; AMOXICILLIN; BACTERIAL DNA; CLARITHROMYCIN; DNA 23S; GUANINE; PROTON PUMP INHIBITOR;

ADULT; AGED; AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BRAZIL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA FRAGMENTATION; DYSPEPSIA; GENE MUTATION; GENETIC CONSERVATION; GENOTYPE; GOLD STANDARD; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MBOII GENE; MIDDLE AGED; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION SITE; SENSITIVITY AND SPECIFICITY; STOMACH BIOPSY; URBAN AREA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRAZIL; CLARITHROMYCIN; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; DYSPEPSIA; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; YOUNG ADULT;

EID: 84888770645     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-164     Document Type: Article

References (50)

1. Megraud F. Helicobacter pylori infection: Review and practice. Presse Med 2010, 39(7-8):815-822.
2. Wilhelmsen I, Berstad A. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. Scand J Gastroenterol 1994, 29(10):874-879. 10.3109/00365529409094856, 7839092.
3. Na HS, Hong SJ, Yoon HJ, Maeng JH, Ko BM, Jung IS, Ryu CB, Kim JO, Cho JY, Lee JS, et al. Eradication rate of first-line and second-line therapy for Helicobacter pylori infection, and reinfection rate after successful eradication. Korean J Gastroenterol 2007, 50(3):170-175.
4. Chisholm SA, Teare EL, Davies K, Owen RJ. Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000-2005). Euro Surveill 2007, 12(7):E3-4.
5. Coelho LG, Zaterka S. Second Brazilian Consensus Conference on Helicobacter pylori infection. Arq Gastroenterol 2005, 42(2):128-132.
6. McNamara D, O'Morain C. Consensus guidelines: agreement and debate surrounding the optimal management of Helicobacter pylori infection. Can J Gastroenterol 2000, 14(6):511-517.
7. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 56(6):772-781. 10.1136/gut.2006.101634, 1954853, 17170018.
8. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007, 102(8):1808-1825. 10.1111/j.1572-0241.2007.01393.x, 17608775.
9. Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol 2011, 8(2):79-88. 10.1038/nrgastro.2010.210, 21293508.
10. Graham DY, Fischbach L. Helicobacter pylori infection. N Engl J Med 2010, 363(6):595-596. author reply 596.
11. Qasim A, O'Morain CA. Review article: treatment of Helicobacter pylori infection and factors influencing eradication. Aliment Pharmacol Ther 2002, 16(Suppl 1):24-30.
12. Wermeille J, Cunningham M, Dederding JP, Girard L, Baumann R, Zelger G, Buri P, Metry JM, Sitavanc R, Gallaz L, et al. Failure of Helicobacter pylori eradication: is poor compliance the main cause?. Gastroenterol Clin Biol 2002, 26(3):216-219.
13. Egan BJ, Marzio L, O'Connor H, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2008, 13(Suppl 1):35-40.
14. Silva FM, Eisig JN, Teixeira AC, Barbuti RC, Navarro-Rodriguez T, Mattar R. Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy. BMC Gastroenterol 2008, 8:20. 10.1186/1471-230X-8-20, 2438368, 18510773.
15. Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 2003, 17(1):99-109. 10.1046/j.1365-2036.2003.01396.x, 12492738.
16. Kato M, Yamaoka Y, Kim JJ, Reddy R, Asaka M, Kashima K, Osato MS, El-Zaatari FA, Graham DY, Kwon DH. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother 2000, 44(8):2214-2216. 10.1128/AAC.44.8.2214-2216.2000, 90045, 10898707.
17. Lee JH, Shin JH, Roe IH, Sohn SG, Kang GH, Lee HK, Jeong BC, Lee SH. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults. Antimicrob Agents Chemother 2005, 49(4):1600-1603. 10.1128/AAC.49.4.1600-1603.2005, 1068646, 15793150.
18. Giorgio F, Principi M, De Francesco V, Zullo A, Losurdo G, Di Leo A, Ierardi E. Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?. World journal of gastrointestinal pathophysiology 2013, 4(3):43-46. 10.4291/wjgp.v4.i3.43, 3740258, 23946886.
19. Mendonca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, Pedrazzoli J. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000, 5(2):79-83. 10.1046/j.1523-5378.2000.00011.x, 10849055.
20. Prazeres Magalhaes P, De Magalhaes Queiroz DM, Campos Barbosa DV, Aguiar Rocha G, Nogueira Mendes E, Santos A, Valle Correa PR, Camargos Rocha AM, Martins Teixeira L. Affonso de Oliveira C: Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil. Antimicrob Agents Chemother 2002, 46(6):2021-2023. 10.1128/AAC.46.6.2021-2023.2002, 127243, 12019131.
21. Ribeiro ML, Vitiello L, Miranda MC, Benvengo YH, Godoy AP, Mendonca S, Pedrazzoli J. Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil. Ann Clin Microbiol Antimicrob 2003, 2:11. 10.1186/1476-0711-2-11, 305369, 14633281.
22. Eisig JN, Silva FM, Barbuti RC, Navarro-Rodriguez T, Moraes-Filho JP, Pedrazzoli J. Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option. Arq Gastroenterol 2011, 48(4):261-264. 10.1590/S0004-28032011000400008, 22147131.
23. Garcia GT, Aranda KR, Goncalves ME, Cardoso SR, Iriya K, Silva NP, Scaletsky IC. High prevalence of clarithromycin resistance and cagA, vacA, iceA2, and babA2 genotypes of Helicobacter pylori in Brazilian children. J Clin Microbiol 2010, 48(11):4266-4268. 10.1128/JCM.01034-10, 3020848, 20826649.
24. Megraud F. Current recommendations for Helicobacter pylori therapies in a world of evolving resistance. Gut Microbes 2013, 4:6.
25. Woo HY, Park DI, Park H, Kim MK, Kim DH, Kim IS, Kim YJ. Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens. Helicobacter 2009, 14(1):22-28. 10.1111/j.1523-5378.2009.00654.x, 19191892.
26. Chisholm SA, Owen RJ, Teare EL, Saverymuttu S. PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples. J Clin Microbiol 2001, 39(4):1217-1220. 10.1128/JCM.39.4.1217-1220.2001, 87913, 11283030.
27. Tajbakhsh S, Samarbaf-Zadeh AR, Moosavian M. Comparison of fluorescent in situ hybridization and histological method for the diagnosis of Helicobacter pylori in gastric biopsy samples. Med Sci Monit 2008, 14(9):BR183-187.
28. Burucoa C, Garnier M, Silvain C, Fauchere JL. Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori. J Clin Microbiol 2008, 46(7):2320-2326. 10.1128/JCM.02352-07, 2446943, 18463216.
29. Suzuki RB, Almeida CM, Speranca MA. Absence of Helicobacter pylori high tetracycline resistant 16S rDNA AGA926-928TTC genotype in gastric biopsy specimens from dyspeptic patients of a city in the interior of Sao Paulo, Brazil. BMC Gastroenterol 2012, 12:49. 10.1186/1471-230X-12-49, 3449196, 22594560.
30. Moazed D, Noller HF. Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie 1987, 69(8):879-884. 10.1016/0300-9084(87)90215-X, 3122849.
31. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997, 41(12):2621-2628. 164180, 9420030.
32. Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, Tanaka SK, Graham DY, Go MF. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996, 40(2):477-480. 163139, 8834903.
33. Stone GG, Shortridge D, Flamm RK, Versalovic J, Beyer J, Idler K, Zulawinski L, Tanaka SK. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1996, 1(4):227-228. 10.1111/j.1523-5378.1996.tb00043.x, 9432314.
34. Toracchio S, Aceto GM, Mariani-Costantini R, Battista P, Marzio L. Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori. Helicobacter 2004, 9(5):396-399. 10.1111/j.1083-4389.2004.00267.x, 15361077.
35. Fontana C, Favaro M, Minelli S, Criscuolo AA, Pietroiusti A, Galante A, Favalli C. New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 2002, 46(12):3765-3769. 10.1128/AAC.46.12.3765-3769.2002, 132752, 12435674.
36. Rimbara E, Noguchi N, Kawai T, Sasatsu M. Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori. Antimicrob Agents Chemother 2008, 52(9):3465-3466. 10.1128/AAC.00445-08, 2533477, 18606842.
37. Scaletsky IC, Aranda KR, Garcia GT, Goncalves ME, Cardoso SR, Iriya K, Silva NP. Application of real-time PCR stool assay for Helicobacter pylori detection and clarithromycin susceptibility testing in Brazilian children. Helicobacter 2011, 16(4):311-315. 10.1111/j.1523-5378.2011.00845.x, 21762271.
38. Lins AK, Lima RA, Magalhaes M. Clarithromycin-resistant Helicobacter pylori in Recife, Brazil, directly identified from gastric biopsies by polymerase chain reaction. Arquivos de gastroenterologia 2010, 47(4):379-382. 10.1590/S0004-28032010000400011, 21225149.
39. van Doorn LJ, Glupczynski Y, Kusters JG, Megraud F, Midolo P, Maggi-Solca N, Queiroz DM, Nouhan N, Stet E, Quint WG. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 2001, 45(5):1500-1504. 10.1128/AAC.45.5.1500-1504.2001, 90495, 11302817.
40. Assumpcao MB, Martins LC, Melo Barbosa HP, Barile KA, de Almeida SS, Assumpcao PP, Corvelo TC. Helicobacter pylori in dental plaque and stomach of patients from Northern Brazil. World J Gastroenterol 2010, 16(24):3033-3039. 10.3748/wjg.v16.i24.3033, 2890944, 20572307.
41. Rotimi O, Cairns A, Gray S, Moayyedi P, Dixon MF. Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol 2000, 53(10):756-759. 10.1136/jcp.53.10.756, 1731087, 11064668.
42. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25(17):3389-3402. 10.1093/nar/25.17.3389, 146917, 9254694.
43. Suzuki RB, Cola RF, Cola LT, Ferrari CG, Ellinger F, Therezo AL, Silva LC, Eterovic A, Speranca MA. Different risk factors influence peptic ulcer disease development in a Brazilian population. World J Gastroenterol 2012, 18(38):5404-5411. 10.3748/wjg.v18.i38.5404, 3471109, 23082057.
44. Morris A, Ali MR, Brown P, Lane M, Patton K. Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error. J Clin Pathol 1989, 42(7):727-732. 10.1136/jcp.42.7.727, 1142023, 2474579.
45. Sugiyama T, Sakaki N, Kozawa H, Sato R, Fujioka T, Satoh K, Sugano K, Sekine H, Takagi A, Ajioka Y, et al. Sensitivity of biopsy site in evaluating regression of gastric atrophy after Helicobacter pylori eradication treatment. Aliment Pharmacol Ther 2002, 16(Suppl 2):187-190.
46. Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007, 20(2):280-322. 10.1128/CMR.00033-06, 1865594, 17428887.
47. Godoy AP, Ribeiro ML, Benvengo YH, Vitiello L, Miranda Mde C, Mendonca S, Pedrazzoli J. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol 2003, 3:20. 10.1186/1471-230X-3-20, 194586, 12911839.
48. Farina N, Kasamatsu E, Samudio M, Moran M, Sanabria R, Laspina F. Antimicrobial susceptibility of H pylori strains obtained from Paraguayan patients. Revista medica de Chile 2007, 135(8):1009-1014.
49. Sakinc T, Baars B, Wuppenhorst N, Kist M, Huebner J, Opferkuch W. Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin. BMC research notes 2012, 5:603. 10.1186/1756-0500-5-603, 3522010, 23110798.
50. Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, Quint WG, Carneiro F. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 2001, 36(2):128-135.